HOME | CONTACT | BLOG | SITE MAP   

Press Releases

VetStem CEO Invited to give Keynote Presentation at the 7th World Congress of Veterinary Dermatology in Vancouver BC

September 01, 2011 --

Poway, California -- Vet-Stem, Inc., announced that Dr. Robert Harman, DVM, MPVM, CEO of Vet-Stem, will present a keynote presentation entitled “Stem Cell Therapy in Veterinary Dermatology – Scientific Evidence and Clinical Approach” at the 7th World Congress of Veterinary Dermatology in Vancouver, British Columbia, July, 2012.

The World Congress in Veterinary Dermatology was initiated by the constituent organizations representing the American, Canadian and European specialists in veterinary dermatology. Attendees are challenged by a scientific program that delivers the latest advancements in veterinary dermatology including clinical and scientific research. The advanced and comprehensive continuing education program and workshops highlight current trends in clinical dermatology practice from around the world. The program is presented at www.vetdermvancouver.com.

Dr. Harman has presented at more than 40 veterinary and human stem cell conferences since the founding of Vet-Stem in 2002. This keynote seminar will present cutting edge research and clinical evidence from the veterinary and human stem cell field relating to applications of regenerative medicine in dermatology. Data from the benchtop to the clinic will be reviewed in the context of evidenced-based medicine as the attendees learn both the science of regenerative medicine and potential practical applications.

Dr. Harman has been at the forefront of development of the practical applications of stem cells in our animal populations and has consulted with a number of human stem cell companies to share these veterinary findings for the benefit of potential therapy of humans.

Vet-Stem’s clinical team has contributed to the industry by providing in-person and online training to over 4,000 veterinarians in the United States and Canada and by providing stem cells for treatment of over 7,000 horses and dogs. Peer-reviewed publications in the journals Veterinary Therapeutics and the American Journal of Veterinary Research have demonstrated the effectiveness of these types of treatments in dogs and horses. “One Medicine” shows the commonality of diseases and treatment between animals and humans and has been a guiding principle at Vet-Stem since its founding.

About Vet-Stem, Inc.

Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. This privately held company delivers stem cell and related services and products to veterinarians to treat diseases in dogs, cats and horses. These technologies utilize the natural healing properties inherent in all animals to reduce pain and improve the quality of life of our animal companions.

In January of 2004, Vet-Stem introduced the first veterinary stem cell service in the United States. There has been rapid adoption of this technology for treatment of tendon, ligament, and joint injuries by the veterinary community. Published studies have confirmed that these stem cells can dramatically improve the healing of injuries and diseases that have had very few treatment options in the past.

CONTACT INFORMATION:
Michael Dale
Chief Operating Officer
Vet-Stem, Inc
Ph: 858-748-2004 ext 102
Fax: 858-748-2005
www.vet-stem.com



< Back to Press Releases     

 


  • Success Stories
    News
    Videos
    Blog
    Press Releases
    Facebook
    Twitter
     


      COMPANY
    Management
    Investors
    Contact Us
    Careers
    Privacy Policy
    SCIENCE
    FAQs
    Literature Refs
    Safety
    PET & HORSE OWNERS
    Dogs & Cats
    Horses
    Locate a Vet
    FAQs
    VETERINARIANS
    Vet Login /
    Credentialing

    Dogs & Cats
    Horses
    FAQs
    MEDIA ROOM
    Press Releases
    Success Stories
    News
    Videos
    Blog
    LOCATE A VET

    CONTACT US
     

    COPYRIGHT 2011 VETSTEM BIOPHARMA. ALL RIGHTS RESERVED.
    12860 Danielson Court, Suite B, Poway, CA 92064 Phone: 858-748-2004 or 888-387-8361